ALMS

ALUMIS INC

ALMS·022307102·US·Common Stock·Healthcare - Biotechnology-Activist

ALMS (ALUMIS INC) is held by 106 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($158M), VANGUARD CAPITAL MANAGEMENT LLC ($88.8M), PRICE T ROWE ASSOCIATES INC /MD/ ($72.4M). Net institutional sentiment: Bullish.

106
Holders
(8 Elite)
$965.2M
Total Value
77% (114)
Consensus
88 buying - 26 selling
13F: Insider & Congress:
ALMSSmart Money Verdict
View all
Held by 106 funds
8 elite
Who's Trading
InsiderPSPangali SanamSell $140KJul 6, 2026
ActivistAYAyurMaya Capital Management Company, LP12.3%Jul 2, 2026
ActivistDTDeep Track Capital, LP6.0%Apr 7, 2026
ActivistFVForesite Capital Fund VI LP3.4%Apr 3, 2026
ActivistSBSamsara BioCapital, L.P.3.8%Jan 13, 2026
InsiderASAKKARAJU SRINIVASBuy $10.0MJan 9, 2026
InsiderFLForesite Labs, LLCBuy $2.0MJan 8, 2026
InsiderFLForesite Capital Management VI LLCBuy $2.0MJan 8, 2026
InsiderTBTananbaum James B.Buy $2.0MJan 8, 2026
InsiderFLForesite Labs, LLCBuy $5.0MJan 8, 2026
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
7.2M(+57.0%)$158M0.0%+112.35%
43
New
4M$88.8M0.0%+0.57%
41
Increased
3.3M(+6418.5%)$72.4M0.0%+1.80%
48
Increased
3.1M(+2579.8%)$67.3M0.0%+3.99%
48
New
2.1M$46.8M0.0%+0.57%
40
Increased
2M(+28.8%)$44.3M0.3%+70.33%
44
Increased
1.9M(+29.0%)$42.3M0.0%+166.95%
37
Increased
1.8M(+43.1%)$39.7M0.0%+139.58%
39
Increased
1.5M(+258.3%)$33.3M0.0%+25.68%
47
Increased
1.2M(+214.5%)$25.8M0.0%+26.72%
46
New
1.1M$23.3M0.0%+0.57%
40
Increased
973,782(+3959.6%)$21.5M0.0%+2.35%
46
Increased
861,575(+141.8%)$17.4M0.0%+52.84%
46
New
749,099$16.5M0.1%+0.57%
39
Increased
718,040(+68.1%)$15.8M0.0%+101.88%
42
New
712,608$15.7M0.0%+0.57%
39
Increased
658,115(+120.7%)$14.5M0.0%+48.26%
45
Increased
635,389(+26.1%)$14M0.0%+183.00%
35
Decreased
606,284(-47.3%)$13.4M0.0%+254.29%
0
Increased
572,129(+146.9%)$12.6M0.0%+36.44%
45

Showing 1-20 of 115

1 / 6

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used